NSC |
Compound |
Enrichment |
Correlation |
NSC 622124 |
Molybdate(6-), hexatriaconta-.mu.-oxooctadecaoxobis[.mu.9-[phosphato(3-)-.kappa.O:.kappa.O:.kappa.O:.kappa.O':.kappa.O':.kappa.O'':.kappa.O'':.kappa.O''':.kappa.O''']]octadeca-, hexapotassium (9CI) |
0.00423163567577548 |
0.41565368 |
NSC 625541 |
Null |
0.00423163567577548 |
-0.019478621 |
NSC 643841 |
Null |
0.00423163567577548 |
-0.084646481 |
NSC 649750 |
Null |
0.00423163567577548 |
-0.085851843 |
NSC 671134 |
Null |
0.00423163567577548 |
-0.29849745 |
NSC 673267 |
IL4(38-37)-PE38KDEL |
0.00423163567577548 |
0.043917979 |
NSC 67586 |
2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, |
0.00423163567577548 |
-0.27171651 |
NSC 682768 |
Null |
0.00423163567577548 |
0.14875548 |
NSC 688274 |
Null |
0.00423163567577548 |
0.099155938 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.00550789647802199 |
0.079553153 |